Schedule 13G ownership disclosure

ASCENDIS PHARMA A/S

ADR · CUSIP: 04351P101

Event date: 2025-03-31

Filing-level shares
3,053,824
Percent of class
5.0%
  • T. Rowe Price Investment Management, Inc.

    Shares: 3,053,824 · Class: 5.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001897612-25-000208
Form type
SCHEDULE 13G
Filer
Ascendis Pharma A/S
CIK
CIK 1612042
Filed
May 14, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub